Similar articles

• The social history of ISIS-2: triumph and the path not taken.

  Keating C. Keating C. Lancet. 2015 Aug 15;386(9994):e4-5. doi: 10.1016/S0140-6736(15)61505-7. Lancet. 2015. PMID: 26334164 No abstract available.
• The social history of ISIS-2: the early history.

  Keating C. Keating C. Lancet. 2015 Aug 15;386(9994):646-7. doi: 10.1016/S0140-6736(15)61493-3. Lancet. 2015. PMID: 26334149 No abstract available.
• ISIS 3: the last word on thrombolysis?

  Cobbe S. Cobbe S. BMJ. 1992 Jun 6;304(6840):1454-5. doi: 10.1136/bmj.304.6840.1454. BMJ. 1992. PMID: 1489396 Free PMC article. No abstract available.
• [Effects of thrombolytic treatments on the mortality of myocardial infarction. Characteristics of large-scale trials, main results].

  Slama M, Cohen-Solal A, Spriet A. Slama M, et al. Arch Mal Coeur Vaiss. 1989 Oct;82 Spec No 3:27-33. Arch Mal Coeur Vaiss. 1989. PMID: 2512885 Review. French.
• Aspirin augmentation of the efficacy of thrombolysis.

  O'Donnell CJ, Jonas MA, Hennekens CH. O'Donnell CJ, et al. Coron Artery Dis. 1995 Dec;6(12):936-9. Coron Artery Dis. 1995. PMID: 8723015 Review. No abstract available.